Stoke Therapeutics (STOK) News Today $15.86 +1.30 (+8.93%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 5:52 AM | msn.comAmbani Wedding in London: Stoke Park Hotel Issues Statement on Anant-Radhika's Function Rumours, Says 'No Event Booked'July 26 at 12:52 AM | uk.news.yahoo.comThree lingering questions for Stoke City to solve as plates spin on burning issuesJuly 26 at 12:52 AM | msn.comDwight Gayle among ex-Stoke City trio searching for end to transfer limbo at PFA free agent campJuly 25 at 2:50 PM | msn.comStoke boss delivers firm message on Bae Junho and Wouter Burger amid Tottenham and Feyenoord transfer talkJuly 25 at 2:50 PM | msn.comMissing Buxton teen last seen at Stoke-on-Trent beauty spot days agoJuly 25 at 2:50 PM | uk.news.yahoo.comSchoolgirl, 13, disappears in Stoke-on-Trent three days ago and hasn't been seen sinceJuly 25 at 2:50 PM | msn.comChange of squad number for Bae Junho as Stoke City leave big vacancyJuly 23, 2024 | msn.comPete Smith's Stoke City player ratings vs Crewe as Andre Vidigal stakes his claim with braceJuly 23, 2024 | msn.comStoke City team news vs Crewe Alexandra as duo returnJuly 23, 2024 | msn.comRecord number of school suspensions in StokeJuly 23, 2024 | msn.comCrash claims life of driver and puts passenger in Royal StokeJuly 22, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading 9.1% Higher Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 9.1%July 21, 2024 | morningstar.comStoke Therapeutics Inc 0GTJuly 20, 2024 | uk.news.yahoo.comStoke City to open bet365 Stadium doors for training sessionJuly 20, 2024 | msn.com'Noisy' Gibson vows to help Stoke 'do good things'July 20, 2024 | msn.comRecord number of gonorrhoea and syphilis cases in StokeJuly 18, 2024 | americanbankingnews.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives $20.57 Consensus Price Target from AnalystsJuly 16, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Purchases Shares of 90,663 Stoke Therapeutics, Inc. (NASDAQ:STOK)Mirae Asset Global Investments Co. Ltd. acquired a new position in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 90,663 shares of the company's stock, valued at approxJuly 15, 2024 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and seven have assigned aJuly 11, 2024 | marketbeat.comWedbush Reiterates "Outperform" Rating for Stoke Therapeutics (NASDAQ:STOK)Wedbush restated an "outperform" rating and set a $17.00 price objective on shares of Stoke Therapeutics in a research report on Thursday.July 4, 2024 | insidertrades.comInsider Selling: Stoke Therapeutics, Inc. (NASDAQ:STOK) Insider Sells 10,000 Shares of StockJuly 3, 2024 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Insider Sells $137,500.00 in StockStoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) insider Barry Ticho sold 10,000 shares of Stoke Therapeutics stock in a transaction dated Monday, July 1st. The stock was sold at an average price of $13.75, for a total value of $137,500.00. Following the completion of the transaction, the insider now directly owns 2,485 shares of the company's stock, valued at $34,168.75. The transaction was disclosed in a document filed with the SEC, which is available at this link.July 2, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Down 3.5%Stoke Therapeutics (NASDAQ:STOK) Trading Down 3.5%June 28, 2024 | marketbeat.comStoke Therapeutics' (STOK) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $22.00 price target on shares of Stoke Therapeutics in a report on Friday.June 26, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Down 5.4%Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.4%June 20, 2024 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Recommendation of "Moderate Buy" from AnalystsStoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and seven have given a buy rJune 18, 2024 | businesswire.comStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)June 14, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Shares Gap Down to $17.52Stoke Therapeutics (NASDAQ:STOK) Shares Gap Down to $17.52June 14, 2024 | seekingalpha.comStoke Therapeutics' STK-001: A Potential Game-Changer For Dravet SyndromeJune 13, 2024 | marketbeat.comBirchview Capital LP Boosts Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)Birchview Capital LP grew its holdings in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 147.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 210,000 shares of the company's stock after purchJune 12, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Hits New 52-Week High at $16.85Stoke Therapeutics (NASDAQ:STOK) Reaches New 12-Month High at $16.85June 11, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading 4.7% Higher Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 4.7%June 7, 2024 | marketbeat.comRTW Investments LP Trims Stake in Stoke Therapeutics, Inc. (NASDAQ:STOK)RTW Investments LP reduced its position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 5.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,131,045 shares of the company's stock after selling 259,5June 6, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Down 7.2%Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 7.2%June 6, 2024 | marketbeat.comTrexquant Investment LP Sells 87,781 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK)Trexquant Investment LP trimmed its holdings in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 68.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 39,800 shares of the company's stock after selling 87,781 shareJune 3, 2024 | businesswire.comStoke Therapeutics to Present at Upcoming Investor Conferences in JuneMay 29, 2024 | msn.com'He's not top, top quality' - Alan Shearer heaps back-handed praise on Stoke City old boyMay 29, 2024 | msn.com'I will not be intimidated!' Diane Abbott vows to stand as MP for Hackney North and Stoke Newington following Labour rowMay 29, 2024 | msn.comPolice and paramedics called out as car hits wall on Stoke roadMay 29, 2024 | msn.com'The best memories of my life' - 'Stoke hero bids farewell to clubMay 29, 2024 | msn.comDeparting Stoke City striker opens up on 'crying for 20 days' after horror injuryMay 29, 2024 | msn.comStoke City defender wins international recall after Glenn Whelan tip-offMay 28, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Shares Down 4% Stoke Therapeutics (NASDAQ:STOK) Shares Down 4%May 28, 2024 | msn.comRishi Sunak insists Stoke-on-Trent will 'continue to be a priority focus'May 26, 2024 | marketbeat.comStoke Therapeutics, Inc. (NASDAQ:STOK) Receives Consensus Rating of "Moderate Buy" from AnalystsStoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommMay 22, 2024 | finance.yahoo.comInsider Sale: CEO Edward M. Kaye of Stoke Therapeutics Inc (STOK) Sells 42,350 SharesMay 22, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Up 7.2%Stoke Therapeutics (NASDAQ:STOK) Trading Up 7.2%May 20, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Hits New 12-Month High at $16.44Stoke Therapeutics (NASDAQ:STOK) Sets New 52-Week High at $16.44May 17, 2024 | businesswire.comStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)May 15, 2024 | marketbeat.comStoke Therapeutics (NASDAQ:STOK) Trading Up 6.4%Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 6.4% Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here STOK Media Mentions By Week STOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STOK News Sentiment▼0.110.61▲Average Medical News Sentiment STOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STOK Articles This Week▼175▲STOK Articles Average Week Get Stoke Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for STOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARCT News HRTX News RVNC News MRSN News STTK News NGM News RYTM News APGE News MLTX News MORF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STOK) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
